FGF23 and heart disorder: As FGF23 is chronically increased in patients with CKD, it is more likely that increased FGF23 concentrations do not improve cardiomyocyte contractility, but rather disturb calcium fluxes, possibly partly explaining early cardiac disease in CKD patients, especially diastolic heart failure, also in the absence of overt hypertrophy.